Development and Validation of Stability Indicating HPTLC Methods for the Estimation of Antihypertensive Drugs (Nebivolol and Hydrochlorothiazide)
DOI:
https://doi.org/10.55544/jrasb.3.3.25Keywords:
ICH, Hypertension, Blood pressure, HPLCAbstract
The devised method passed the ICH Q2 (R1) validation test, and the findings imply it might be utilised for both the regular monitoring of pharmaceutical formulation and raw material quality. Results for Nebivolol and Hydrochlorothiazide were consistently linear across concentration ranges of 4-24 and 10-60 μg/mL, respectively, according to the linearity study. The proposed approach was determined to be appropriate based on precision data and minimal relative standard deviation (RSD). Our lab confirmed the LOD and LOQ values for cilnidipine and lisinopril dihydrate. The method's accuracy within the given range is demonstrated by the low relative standard deviation (RSD) values. We found that the suggested method was linear, sensitive, accurate, and exact when it came to estimating hydrochlorothiazide and nebivolol in bulk and in pharmaceutical formulations. This conclusion was reached when the validation inquiry was finished and the results were discovered.
Downloads
Metrics
References
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 . international society of hypertension global hypertension practice guidelines. Hypertension. (2020). 75:1334–57. 10.1161/HYPERTENSIONAHA.120.15026
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. (2020) 16:223–37. 10.1038/s41581-019-0244-2
Sudharsanan N, Theilmann M, Kirschbaum TK, Manne-Goehler J, Azadnajafabad S, Bovet P, et al. Variation in the proportion of adults in need of blood pressure–lowering medications by hypertension care guideline in low- and middle-income countries. Circulation. (2021) 143:991–1001. 10.1161/CIRCULATIONAHA.120.051620
Fang J, Chang T, Wang G, Loustalot F. Association between cost-related medication nonadherence and hypertension management among us adults. Am J Hypert. (2020) 33:879–86. 10.1093/ajh/hpaa072
Parati G, Kjeldsen S, Coca A, Cushman WC, Wang J. Adherence to single-pill versus free-equivalent combination therapy in hypertension. Hypertension. (2021) 77:692–705. 10.1161/HYPERTENSIONAHA.120.15781
Campana E, Cunha V, Glaveckaite S, Gruev I, Lamirault G, Lehmann E, et al. The use of single-pill combinations as first-line treatment for hypertension: translating guidelines into clinical practice. J Hypertens. (2020) 38:2369–77. 10.1097/HJH.0000000000002598
Tsioufis K, Kreutz R, Sykara G, van Vugt J, Hassan T. Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: a rapid evidence assessment of recent literature. J Hypert. (2020) 38:1016–28. 10.1097/HJH.0000000000002381
Segers P, Rietzschel ER, Chirinos JA. How to measure arterial stiffness in humans. Arterioscl Throm Vasc Biol. (2020) 40:1034–43. 10.1161/ATVBAHA.119.313132
Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. (2012) 308:875–81. 10.1001/2012.jama.10503
Dumor K, Shoemaker-Moyle M, Nistala R, Whaley-Connell A. Arterial stiffness in hypertension: an update. Curr Hypertens Rep. (2018) 20:72. 10.1007/s11906-018-0867-x
Chirinos JA, Segers P, Hughes T, Townsend R. Large-artery stiffness in health and disease: jacc state-of-the-art review. J Am Coll Cardiol. (2019) 74:1237–63. 10.1016/j.jacc.2019.07.012
Wilson J, Webb AJS. Systolic blood pressure and longitudinal progression of arterial stiffness: a quantitative meta-analysis. J Am Heart Assoc. (2020) 9:e017804–017804. 10.1161/JAHA.120.017804
Zanoli L, Briet M, Empana JP, Cunha PG, Mäki-Petäjä KM, Protogerou AD, et al. Vascular consequences of inflammation: a position statement from the esh working group on vascular structure and function and the artery society. J Hypertens. (2020) 38:1682–98. 10.1097/HJH.
Tocci G, Battistoni A, Passerini J, Musumeci MB, Francia P, Ferrucci A, et al. Calcium channel blockers and hypertension. J Cardiovas Pharmacol Ther. (2014) 20:121–30. 10.1177/1074248414555403
Kraehling JR, Sessa WC. Contemporary approaches to modulating the nitric oxide–cgmp pathway in cardiovascular disease. Circ Res. (2017) 120:1174–82. 10.1161/CIRCRESAHA.117.303776
Garcia V, Sessa WC. Endothelial nos: perspective and recent developments. Br J Pharmacol. (2019) 176:189–96. 10.1111/bph.14522
Farah C, Michel LYM, Balligand JL. Nitric oxide signalling in cardiovascular health and disease. Nat Rev Cardiol. (2018) 15:292–316. 10.1038/nrcardio.2017.224
Sanyour HJ, Li N, Rickel AP, Childs JD, Kinser CN, Hong Z. Membrane cholesterol and substrate stiffness co-ordinate to induce the remodelling of the cytoskeleton and the alteration in the biomechanics of vascular smooth muscle cells. Cardiovasc Res. (2019) 115:1369–80. 10.1093/cvr/cvy276
Gérard, A., Woolfe, A., Mottet, G., Reichen, M., Castrillon, C., Menrath, V., ... & Brenan, C. (2020). High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics. Nature biotechnology, 38(6), 715-721.
Chattopadhyay A, Kwartler CS, Kaw K, Li Y, Kaw A, Chen J, et al. Cholesterol-induced phenotypic modulation of smooth muscle cells to macrophage/fibroblast-like cells is driven by an unfolded protein response. Arterioscler Thromb Vasc Biol. (2021) 41:302–16. 10.1161/ATVBAHA.120.315164
Yap C, Mieremet A, de Vries CJM, Micha D, de Waard V. Six shades of vascular smooth muscle cells illuminated by klf4 (krüppel-like factor 4). Arterioscler Thromb Vasc Biol. (2021) 41:2693–707. 10.1161/ATVBAHA.121.316600
Chandran RR, Xie Y, Gallardo-Vara E, Adams T, Garcia-Milian R, Kabir I, et al. Distinct roles of klf4 in mesenchymal cell subtypes during lung fibrogenesis. Nat Commun. (2021) 12:7179. 10.1038/s41467-021-27499-8
Sun D, Ding D, Li Q, Xie M, Xu Y, Liu X. The preventive and therapeutic effects of aav1-klf4-shrna in cigarette smoke-induced pulmonary hypertension. J Cell Mol Med. (2021) 25:1238–51. 10.1111/jcmm.16194
Sun D, Li Q, Ding D, Li X, Xie M, Xu Y, et al. Role of krüppel-like factor 4 in cigarette smoke-induced pulmonary vascular remodeling. Am J Transl Res. (2018) 10:581–91.
Roush GC, Sica DA. Diuretics for hypertension: a review and update. Am J Hypert. (2016) 29:1130–7. 10.1093/ajh/hpw030
Awuchi, C. G., Amagwula, I. O., Priya, P., Kumar, R., Yezdani, U., & Khan, M. G. (2020). Aflatoxins in foods and feeds: A review on health implications, detection, and control. Bull. Environ. Pharmacol. Life Sci, 9, 149-155.
Kaur, R. P., Vasudeva, K., Kumar, R., & Munshi, A. (2018). Role of p53 gene in breast cancer: focus on mutation spectrum and therapeutic strategies. Current pharmaceutical design, 24(30), 3566-3575.
Morris RC, Schmidlin O, Sebastian A, Tanaka M, Kurtz TW. Vasodysfunction that involves renal vasodysfunction, not abnormally increased renal retention of sodium, accounts for the initiation of salt-induced hypertension. Circulation. (2016) 133:881–93. 10.1161/CIRCULATIONAHA.115.017923
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Anamika, Roshan Kumar, Subham Kumar, Priya Singh, Puja Kumari, Abhishek Kumar, Rajeev Ranjan Raj, Kritika Singh, Ravi Ranjan Raj
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.